Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 4.325
8.67 %
$ 90.3 M
Market Cap
-4.7
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
20.99%
EBIT
Estimate
--104.46%
Net Income
Estimate
57.63%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Journey Medical Corporation
DERM has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart DERM
EBIT FORECAST
EBIT Forecast Chart DERM
NET INCOME FORECAST
Net Income Chart DERM